BMS Launches New Auto-Injector for Orencia
By

Bristol-Myers Squibb (BMS) has launched Orencia (abatacept) ClickJect autoinjector, a new self-administered autoinjector for adults with moderate-to-severe rheumatoid arthritis (RA) that delivers 125 mg of subcutaneous Orencia. Orencia is a biologic that is offered in three administration options: IV infusion, prefilled syringe, and now autoinjector.

Source: BMS

Leave a Reply

Your email address will not be published.